Stability of ofloxacin in peritoneal dialysis solutions.
Battista
C
C
Department of Pharmacy Practice, Albany College of Pharmacy, New York, U.S.A.
Kane
M P
MP
Moon
D G
DG
Bailie
G R
GR
D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D002851:Chromatography, High Pressure Liquid; D015314:Dialysis Solutions / Q000737:chemistry*; D004355:Drug Stability; D006801:Humans; D015994:Incidence; D015242:Ofloxacin / Q000008:administration & dosage / Q000737:chemistry*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors
D015314:Dialysis Solutions; D015242:Ofloxacin